NeuBase Therapeutics Inc NBSE

NeuBase Therapeutics Inc

Biotechnology

Healthcare

NBSE

1.69 M shares

NASDAQ US

traded

08 Sep 2023

listed

yes

open

1.63

52 week high

5.35

high

1.74

52 week low

1.32

low

1.28

growth

-41.85 %

previous Close

1.87

P/E ratio

-1

market cap

1.26 M

div yield

0

usd

Jun 2023

qoq

revenue

0.00 %

net incoming

-3.45 M

0.00 %

eps

-2.04 %

-1.00 %

eps surprise

-2.00 %

net profit margin

-344679400.00 %

0.00 %

operating incoming

-3.69 M

0.00 %

net change in cash

902 K

0.00 %

cash on hand

14.75 M

0.00 %

cost of revenue

0.00 %